Logo image of OTRK

ONTRAK INC (OTRK) Stock Fundamental Analysis

NASDAQ:OTRK - Nasdaq - US6833734014 - Common Stock - Currency: USD

1.38  -0.01 (-0.72%)

After market: 1.33 -0.05 (-3.62%)

Fundamental Rating

1

Taking everything into account, OTRK scores 1 out of 10 in our fundamental rating. OTRK was compared to 103 industry peers in the Health Care Providers & Services industry. OTRK has a bad profitability rating. Also its financial health evaluation is rather negative. OTRK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OTRK has reported negative net income.
In the past year OTRK has reported a negative cash flow from operations.
In the past 5 years OTRK always reported negative net income.
OTRK had a negative operating cash flow in each of the past 5 years.
OTRK Yearly Net Income VS EBIT VS OCF VS FCFOTRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -445.78%, OTRK is not doing good in the industry: 97.09% of the companies in the same industry are doing better.
OTRK's Return On Equity of -1752.70% is on the low side compared to the rest of the industry. OTRK is outperformed by 85.44% of its industry peers.
Industry RankSector Rank
ROA -445.78%
ROE -1752.7%
ROIC N/A
ROA(3y)-265.11%
ROA(5y)-172.32%
ROE(3y)-706.96%
ROE(5y)-452.52%
ROIC(3y)N/A
ROIC(5y)N/A
OTRK Yearly ROA, ROE, ROICOTRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

With an excellent Gross Margin value of 57.60%, OTRK belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
OTRK's Gross Margin has improved in the last couple of years.
OTRK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y8.5%
OTRK Yearly Profit, Operating, Gross MarginsOTRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

OTRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OTRK has more shares outstanding than it did 1 year ago.
OTRK has more shares outstanding than it did 5 years ago.
OTRK has a worse debt/assets ratio than last year.
OTRK Yearly Shares OutstandingOTRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
OTRK Yearly Total Debt VS Total AssetsOTRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

Based on the Altman-Z score of -44.85, we must say that OTRK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -44.85, OTRK is not doing good in the industry: 94.17% of the companies in the same industry are doing better.
OTRK has a Debt/Equity ratio of 2.05. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.05, OTRK is not doing good in the industry: 74.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Altman-Z -44.85
ROIC/WACCN/A
WACC6.47%
OTRK Yearly LT Debt VS Equity VS FCFOTRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.72 indicates that OTRK may have some problems paying its short term obligations.
OTRK has a worse Current ratio (0.72) than 85.44% of its industry peers.
A Quick Ratio of 0.72 indicates that OTRK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.72, OTRK is doing worse than 78.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
OTRK Yearly Current Assets VS Current LiabilitesOTRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

OTRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.41%.
Looking at the last year, OTRK shows a very negative growth in Revenue. The Revenue has decreased by -21.03% in the last year.
The Revenue for OTRK have been decreasing by -20.93% on average. This is quite bad
EPS 1Y (TTM)-61.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-21.03%
Revenue growth 3Y-49.48%
Revenue growth 5Y-20.93%
Sales Q2Q%-24.74%

3.2 Future

Based on estimates for the next years, OTRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.54% on average per year.
Based on estimates for the next years, OTRK will show a very strong growth in Revenue. The Revenue will grow by 65.61% on average per year.
EPS Next Y45.86%
EPS Next 2Y27.35%
EPS Next 3Y26.88%
EPS Next 5Y15.54%
Revenue Next Year48.09%
Revenue Next 2Y51.63%
Revenue Next 3Y58.54%
Revenue Next 5Y65.61%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OTRK Yearly Revenue VS EstimatesOTRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
OTRK Yearly EPS VS EstimatesOTRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OTRK. In the last year negative earnings were reported.
Also next year OTRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTRK Price Earnings VS Forward Price EarningsOTRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTRK Per share dataOTRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

OTRK's earnings are expected to grow with 26.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.35%
EPS Next 3Y26.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OTRK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONTRAK INC

NASDAQ:OTRK (6/20/2025, 8:00:02 PM)

After market: 1.33 -0.05 (-3.62%)

1.38

-0.01 (-0.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-20 2025-05-20/amc
Earnings (Next)08-06 2025-08-06
Inst Owners15.91%
Inst Owner Change539.84%
Ins Owners0.03%
Ins Owner Change0%
Market Cap5.82M
Analysts82.86
Price Target4.08 (195.65%)
Short Float %0.76%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.61%
Min EPS beat(2)-30.46%
Max EPS beat(2)1.23%
EPS beat(4)1
Avg EPS beat(4)-31.68%
Min EPS beat(4)-86.27%
Max EPS beat(4)1.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-20.84%
Min Revenue beat(2)-41.84%
Max Revenue beat(2)0.16%
Revenue beat(4)1
Avg Revenue beat(4)-13.1%
Min Revenue beat(4)-41.84%
Max Revenue beat(4)0.16%
Revenue beat(8)1
Avg Revenue beat(8)-24.66%
Revenue beat(12)1
Avg Revenue beat(12)-23.76%
Revenue beat(16)4
Avg Revenue beat(16)-16.46%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.63
EYN/A
EPS(NY)-2.89
Fwd EYN/A
FCF(TTM)-3.1
FCFYN/A
OCF(TTM)-3.06
OCFYN/A
SpS2.41
BVpS1.1
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -445.78%
ROE -1752.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.6%
FCFM N/A
ROA(3y)-265.11%
ROA(5y)-172.32%
ROE(3y)-706.96%
ROE(5y)-452.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y8.5%
F-Score2
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.45%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z -44.85
F-Score2
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)14.24%
Cap/Depr(5y)49.22%
Cap/Sales(3y)3.95%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y45.86%
EPS Next 2Y27.35%
EPS Next 3Y26.88%
EPS Next 5Y15.54%
Revenue 1Y (TTM)-21.03%
Revenue growth 3Y-49.48%
Revenue growth 5Y-20.93%
Sales Q2Q%-24.74%
Revenue Next Year48.09%
Revenue Next 2Y51.63%
Revenue Next 3Y58.54%
Revenue Next 5Y65.61%
EBIT growth 1Y-8.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y31.42%
EBIT Next 5Y30.92%
FCF growth 1Y32.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.01%
OCF growth 3YN/A
OCF growth 5YN/A